BioNews Clinical Will Bring Trials Into ‘Continuum’ of MS Care & Ed Tobias' 50th College Reunion

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare and chronic disorders who want to participate.

Price also reads “3 Things I Discovered at My 50th College Reunion”, a column by Ed Tobias.

===================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/